Not applicableStudy completedNCT00648284What this trial is testingCardiovascular (CV) Risk Evaluation In Type 2 Diabetes SubjectsWho this might be right forType 2 Diabetes MellitusCV Risk GlaxoSmithKline 1,100
Large-scale testing (Phase 3)Looking for participantsNCT07000357What this trial is testingA Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First EventWho this might be right forCardiovascular Disease AstraZeneca 15,100
Post-approval studies (Phase 4)UnknownNCT00217178What this trial is testingHomocysteine Lowering and Atherosclerosis Reduction Trial (HART)Who this might be right forAtherosclerosisCardiovascular Disease Hamilton Health Sciences Corporation 900
Large-scale testing (Phase 3)Study completedNCT01516541What this trial is testingDalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular DiseaseWho this might be right forCardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Hoffmann-La Roche 2,220
Not applicableEnrolling By InvitationNCT07363980What this trial is testingCoronary Computed Tomography Angiography In Rheumatoid Arthritis StudyWho this might be right forRheumatoid ArthritisAtherosclerotic Ischemic DiseasePulmonary Disease+14 more Ellen Margrethe Hauge 4,000
Not applicableStudy completedNCT01630928What this trial is testingRenal Sympathetic Denervation and Potential Effects on Glucose Metabolism and Cardiovascular Risk-FactorsWho this might be right forHypertension, Resistant to Conventional Therapy University Hospital of North Norway 50
Large-scale testing (Phase 3)Study completedNCT02104817What this trial is testingOutcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With HypertriglyceridemiaWho this might be right forEligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD) AstraZeneca 13,078
Not applicableStudy completedNCT00921752What this trial is testingC2 -CORVUS Cholesterol-Control (C2) Controlled Targets for High Vascular Risk Patients Using Effective Statins (CORVUS)Who this might be right forCardiovascular Risk AstraZeneca 1,500
Post-approval studies (Phase 4)Study completedNCT00327418What this trial is testingCARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV EventsWho this might be right forMajor Coronary EventCerebrovascular AccidentCoronary Artery Bypass Graft+2 more Pfizer 2,800
Not applicableStudy completedNCT07088718What this trial is testingPrediction of the SURPASS-CVOT Cardiovascular Outcome Trial in Healthcare Claims DataWho this might be right forType 2 DiabetesMajor Adverse Cardiac EventsCardiovascular (CV) Risk Brigham and Women's Hospital 44,671
Not applicableTemporarily pausedNCT01740739What this trial is testingEvaluation Using ClearView in Determining Association to the Cardiac Risk FactorsWho this might be right forCardiovascular DiseasesCoronary Artery Disease Epic Research & Diagnostics, Inc. 60
Large-scale testing (Phase 3)Looking for participantsNCT05918861What this trial is testingEffect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSWho this might be right forAcute Coronary Syndrome DalCor Pharmaceuticals 2,000
Not applicableUnknownNCT04359927What this trial is testingLong-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 RegistryWho this might be right forSars-CoV2Covid19Cardiovascular Diseases+1 more Hospital Clinic of Barcelona 4,538
Not applicableUnknownNCT01236820What this trial is testingA Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic PatientsWho this might be right forCardiovascular DiseaseChronic Kidney Disease PatientsHemodialytic Patients+2 more China Medical University Hospital 48
Large-scale testing (Phase 3)Study completedNCT00799903What this trial is testingThe Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy TrialWho this might be right forAtherosclerosis GlaxoSmithKline 15,828
Not applicableNot Yet RecruitingNCT07427589What this trial is testingProspective Evaluation of New Metrics to Assess Cardiovascular Remodeling in Obstructive Sleep ApneaWho this might be right forObstructive Sleep ApneaCardiovascular (CV) Risk University Hospital, Antwerp 270
Not applicableStudy completedNCT01853839What this trial is testingImpact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk PatientsWho this might be right forHypertension Boehringer Ingelheim 1,674
Not applicableLooking for participantsNCT05693857What this trial is testingPerceive and Calculated CV RiskWho this might be right forPatient-Perceived Versus Chinese University of Hong Kong 1,500
Not applicableStudy completedNCT00626379What this trial is testingExamining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])Who this might be right forCoronary DiseaseCardiovascular Diseases Northwestern University 1,395
Not applicableEnded earlyNCT04050982What this trial is testingFeasibility Study to Improve AF Outcomes Using a Digital Application for CV Risk ReductionWho this might be right forAtrial Fibrillation Stanford University 11